X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (316) 316
humans (230) 230
animals (167) 167
norovirus (144) 144
caliciviridae infections - virology (142) 142
gastroenteritis (125) 125
viruses (105) 105
gastroenteritis - virology (94) 94
microbiology (85) 85
female (81) 81
male (79) 79
norovirus - drug effects (76) 76
caliciviridae infections - prevention & control (74) 74
caliciviridae infections - epidemiology (73) 73
virology (72) 72
health aspects (71) 71
infectious diseases (69) 69
mice (60) 60
norovirus - physiology (59) 59
caliciviridae infections - drug therapy (57) 57
feline calicivirus (56) 56
norovirus - isolation & purification (56) 56
united-states (55) 55
infections (54) 54
norwalk virus (54) 54
cats (53) 53
infection (50) 50
analysis (49) 49
antiviral agents - pharmacology (49) 49
research (49) 49
diarrhea (48) 48
gastroenteritis - epidemiology (48) 48
murine norovirus (48) 48
norovirus - genetics (48) 48
caliciviridae infections - immunology (45) 45
cell line (44) 44
immunology (44) 44
virus diseases (41) 41
article (40) 40
biotechnology & applied microbiology (39) 39
caliciviridae infections - veterinary (39) 39
replication (38) 38
adult (36) 36
disease outbreaks (35) 35
food science & technology (35) 35
middle aged (34) 34
disease (32) 32
gastroenteritis - prevention & control (32) 32
norovirus - immunology (32) 32
outbreaks (32) 32
epidemiology (31) 31
norovirus - pathogenicity (29) 29
antiviral agents (27) 27
caliciviridae infections - diagnosis (27) 27
inactivation (27) 27
proteins (27) 27
risk factors (27) 27
aged (26) 26
blood group antigens (26) 26
calicivirus, feline - drug effects (26) 26
veterinary sciences (26) 26
caliciviridae infections - transmission (25) 25
child, preschool (25) 25
feces - virology (25) 25
rna (25) 25
adolescent (24) 24
research article (24) 24
caliciviridae - drug effects (23) 23
child (23) 23
fluids and secretions (23) 23
public, environmental & occupational health (23) 23
antiviral agents - therapeutic use (22) 22
children (22) 22
disinfectants - pharmacology (22) 22
epidemics (22) 22
food contamination & poisoning (22) 22
food microbiology (22) 22
gastroenteritis - immunology (22) 22
public health (22) 22
disease models, animal (21) 21
foodborne diseases - virology (21) 21
infant (21) 21
outbreak (21) 21
viral vaccines - immunology (21) 21
virus (21) 21
gastroenteritis - drug therapy (20) 20
hepatitis-a virus (20) 20
in-vitro (20) 20
prevention (20) 20
retrospective studies (20) 20
vaccines (20) 20
virus inactivation - drug effects (20) 20
virus replication - drug effects (20) 20
caliciviridae infections - complications (19) 19
caliciviridae infections - pathology (19) 19
norovirus - growth & development (19) 19
norwalk-like viruses (19) 19
polymerase chain reaction (19) 19
studies (19) 19
vaccine (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, pp. e41619 - e41619
The lack of an animal model for human norovirus (HuNoV) has hindered the development of therapeutic strategies. This study demonstrated that a commonly used... 
UNITED-STATES | PATHOGENESIS | RESPONSES | SYNDROME VIRUS | MULTIDISCIPLINARY SCIENCES | DISEASE | GENE-EXPRESSION | HEPATITIS-C | GASTROENTERITIS | STATINS | PORCINE RESPIRATORY CORONAVIRUS | Intestines - drug effects | Interferon-alpha - pharmacology | Caliciviridae Infections - virology | Virus Shedding - drug effects | Enterocytes - metabolism | Cholesterol - blood | Humans | Sus scrofa - blood | NF-kappa B - metabolism | Simvastatin - pharmacology | Feces - virology | Macrophages - virology | Intestines - virology | Dendritic Cells - drug effects | Dendritic Cells - virology | Norovirus - drug effects | Caliciviridae Infections - immunology | Disease Models, Animal | Receptors, LDL - genetics | Virus Replication - drug effects | Antiviral Agents - pharmacology | Disease Susceptibility | Intestines - pathology | Norovirus - pathogenicity | Caliciviridae Infections - pathology | Receptors, LDL - metabolism | Germ-Free Life - drug effects | Sus scrofa - virology | Toll-Like Receptor 3 - metabolism | Gene Expression Regulation - drug effects | Interferon-alpha - administration & dosage | Phenotype | Animals | Enterocytes - drug effects | Interferon Regulatory Factor-3 - metabolism | Macrophages - drug effects | Viral Load - drug effects | Blood Group Antigens - metabolism | Drugs | Shedding | Veterinary colleges | Transcription factors | Viruses | Innate immunity | Infections | Macrophages | Veterinary medicine | Immunity | Proteins | Signal transduction | Swine | Infectivity | Toll-like receptors | Blood groups | Immunomodulators | Food | Carbohydrates | Antigens | Medical research | Dendritic cells | Immunomodulation | Simvastatin | Poly (I:C) | Preventive medicine | Gene expression | Biological assays | Cholesterol | Immune systems | Studies | Disease prevention | Hogs | Signaling | Enterocytes | Interferon regulatory factor 3 | Interferon | Interferon regulatory factor | Viral infections | Index Medicus
Journal Article
Journal Article
Science Translational Medicine, ISSN 1946-6234, 02/2016, Volume 8, Issue 327, pp. 327ra25 - 327ra25
Journal Article
PLoS Pathogens, ISSN 1553-7366, 07/2012, Volume 8, Issue 7, pp. 43 - e1002783
Ubiquitin (Ub) is a vital regulatory component in various cellular processes, including cellular responses to viral infection. As obligate intracellular... 
CELLS | MURINE NOROVIRUS | MICROBIOLOGY | NORWALK VIRUS-RNA | UBIQUITINATION | IN-VITRO | REPLICATION | VIROLOGY | PATHWAY | PROTEASOME | DEGRADATION | INFECTION | PARASITOLOGY | Caliciviridae Infections - virology | Nitriles - pharmacology | Sindbis Virus - drug effects | Humans | Ubiquitin - metabolism | La Crosse virus - drug effects | X-Box Binding Protein 1 | DNA-Binding Proteins - metabolism | Macrophages - virology | RNA Interference | Norwalk virus - drug effects | Ubiquitin Thiolesterase - metabolism | Membrane Proteins - metabolism | Norovirus - drug effects | Ubiquitin Thiolesterase - antagonists & inhibitors | Protein-Serine-Threonine Kinases - metabolism | Norovirus - physiology | Cell Line | Unfolded Protein Response - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Encephalomyocarditis virus - drug effects | Encephalomyocarditis virus - pathogenicity | Enzyme Inhibitors - pharmacology | Ubiquitin Thiolesterase - genetics | Regulatory Factor X Transcription Factors | Caliciviridae Infections - drug therapy | Transcription Factors - metabolism | Cyanoacrylates | Animals | La Crosse virus - pathogenicity | Cell Line, Tumor | Sindbis Virus - pathogenicity | Mice | Pyridines - pharmacology | RNA, Small Interfering | Norwalk virus - metabolism | Virus diseases | Ubiquitin | Antiviral agents | Research | Observations | Studies | Enzymes | Cell culture | Postal & delivery services | Peptides | Protein folding | Mortality | Viruses | Infections | Experiments | Viral infections | Index Medicus
Journal Article
Journal Article
Science, ISSN 0036-8075, 11/2014, Volume 346, Issue 6210, pp. 755 - 759
Journal Article
Journal Article
Journal of Virology, ISSN 0022-538X, 11/2013, Volume 87, Issue 21, pp. 11798 - 11805
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
IMMUNITY | MURINE NOROVIRUS | VIROLOGY | PRIOR NONRESPONSE |